Neoadjuvant Herceptin in Patients With Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: BREAST CANCER
Interventions: DRUG: Herceptin
Sponsor: Mothaffar Rimawi
Collaborators: Genentech, Inc.